Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Scientific Congress on pursuit of Wisdom in Drug Discovery Chemistry
- Drug Discovery 2020

Welcome message

We unconditionally welcome each and every member of the world from colleges, research  foundations, demonstrative organizations and all interested parties to the Annual summit on Drug Discovery Chemistry, which addresses the ever expanding field of  pharmaceuticals with a major impact on prognosis, therapeutic applications and recent discoveries in  pharmaceutical chemistry during June 01-02, 2020 in Vienna, Austria.

The Drug Discovery 2020 is dedicated to providing a stage for making up a discourse between undertakings and academic associations and moving from research to industry. As such it will offer a great opportunity for the attendees to enhance their knowledge and expertise, display their work and experience in a simulating and challenging international environment. Our endeavour is to provide a thought provoking scientific program.

Drug Discovery 2020 will provide a forum for leading scientists and business leaders and investors to exchange ideas and authoritative views in this exciting field. It maximizes the opportunities to interact with and learn from your peers from across the world.

The productive meeting program includes full addresses, breakout sessions, board exchange, pitch features on a variety of topics and various programs for members from different nations around the globe.

Vienna has one of the world's best healthcare systems, with international access to medical services exemplary.

We hope you join us and take little time to enjoy the unique charm of the region.

Regards,
Organizing Committee
Drug Discovery Chemistry.

About the conference

From June 01-02, 2020, the Annual Summit On  Drug Discovery Chemistry is to be held in Vienna, Austria, we are really looking forward to welcoming you to this incredible meeting of outstanding scientists from around the world and discussing new drug discovery and development achievements.  Over the past few years, there has been a growing demand for specialty medicines, which are expected to ultimately influence the small molecule drug discovery market in a very positive way, as most of the specialty medicines are small molecules.

The gradual increase in health care expenditure regionally contributes to the advancement of new pharmaceutical technology. Although there is a desire to redirect resources with high expenditure, the transition to higher usability of health care expenditure for the development of drugs is below progress.

Drug Discovery 2020 is a global overview the theme “Scientific congress in pursuit of wisdom on Drug Discovery Chemistry”. It would provide a forum for interaction between world-renowned research institutes, universities and businesses, governments, associations and societies among specialists, directors, professors, students, experts and research fellows. This seeks to promote scientific discoveries in the pharmaceutical and chemistry field in order to exchange information on their current progress in science.

WHY TO ATTEND THE CONFERENCE?

Drug Discovery 2020’s aim and intent is to bridge basic and clinical dimensions of recent pharmaceutical chemistry discovery and science. The summit focuses on different groups of therapeutic agents, clinical trial outcomes, new interventional therapy and other trending topics in medical chemistry.

 The conference will provide an ideal platform for knowledge transfer, Business to Business networking and collaboration along with a wonderful scientific meeting experience.

FOCUS OF THE CONFERENCE

         Sharing the insights, experiences and strategies of experts in drug discovery.

         Discover the latest trends in drug chemistry.

         Know the growing demand for drug discovery and pharmaceutical chemistry.

         Find out how progress is being made in scientific formulation in practice.

         Discover the tried and tested bio availability routes.

With people from around the globe focused on finding out about Chemistry, Medicinal Science, Pharmaceutical Science, Natural Science and Inorganic Science this is your best chance to reach the largest range of participants.

We anticipate a phenomenal gathering with the great researchers from different nations and religions around the globe and sharing new and energetic results in the revelation, advancement and medication structure to be held in June 01-02, 2020 in Vienna, Austria.

Sessions /Tracks

Session on Medicinal and Pharmaceutical Research Chemistry

Pharmaceutical and Medicinal chemistry are disciplines at the intersection of synthetic organic chemistry and pharmacology. They are involved in drug design, chemical synthesis and drug development. The most common practice of medicinal chemistry focusing on small organic molecules encompasses synthetic organic chemistry and the combination of chemical biology, enzymology and structural biology with the aim of discovering and developing new therapeutic agents.

Related societies / Associations: The European Federation for Medicinal Chemistry | Royal Society of Medicinal Chemistry | ACS Division of Medicinal Chemistry | American Association of Pharmaceutical Scientists | European Chemical Society | German Chemical Society | International Society for Nucleosides, Nucleotides and Nucleic Acids | Serbian Chemical Society |Association of the British Pharmaceutical Industry  

Recommended: Drug discovery chemistry conference | Medicinal chemistry congress | Pharmaceutical chemistry conference | Drug chemistry Symposia | Drug Discovery meeting | Medicinal chemistry meeting | Pharmaceutical Drugs meet | Congress on Drug Discovery

Session on Nanotechnology in Drug Discovery

Nanotechnology plays an important role in the field of drug discovery and development. It currently lies in the improvement of diagnostic methods, the development of improved drug formulations and delivery systems for disease therapy.

Related societies / Associations: Royal Society of Medicinal Chemistry | German Chemical Society |Serbian Chemical Society  | Association of the British Pharmaceutical Industry  | ACS Division of Medicinal Chemistry | American Association of Pharmaceutical Scientists  | European Chemical Society | The European Federation for Medicinal Chemistry | International Society for Nucleosides, Nucleotides and Nucleic Acids

Recommended: Medicinal chemistry congress | Drug chemistry Symposia| Drug discovery chemistry conference| Pharmaceutical chemistry conference | Pharmaceutical Drugs meet| Drug Discovery meeting | Congress on Drug Discovery| Medicinal chemistry meeting

Session on Molecular Docking

Molecular docking in pharmaceutical chemistry is a kind of bioinformatics modeling that involves two or more molecules interacting to provide a stable adduct. This predicts the three-dimensional structure of any complex, based on the binding properties of the ligand and target. Molecular docking produces various possible structures of adduct that are graded and grouped together using the software scoring feature. The main goal of molecular docking is to achieve ligand-receptor complex with optimized conformation and the purpose to have less binding free energy.

Related societies / Associations: American Association of Pharmaceutical Scientists | International Society for Nucleosides, Nucleotides and Nucleic Acids | Serbian Chemical Society | German Chemical Society | Royal Society of Medicinal Chemistry  | European Chemical Society  | Association of the British Pharmaceutical Industry  | The European Federation for Medicinal Chemistry | ACS Division of Medicinal Chemistry

Recommended: Pharmaceutical chemistry conference | Medicinal chemistry congress | Drug discovery chemistry conference | Medicinal chemistry meeting| Drug chemistry Symposia| Drug Discovery meeting | Congress on Drug Discovery| Pharmaceutical Drugs meet

Session on GABAA Receptors

The GABAA receptors in mammalian brain are the major inhibitory neurotransmitter receptors. Each isoform is made up of five homologous or similar subunits surrounding a GABA-gated central chloride ion-selective channel. The GABA receptor binds to the active site of GABA and several drugs, including muscimol, gaboxadol and bicullin. The receptors activities are indirectly modulated by various allosteric binding sites of the proteins.

Related societies / Associations: European Chemical Society | ACS Division of Medicinal Chemistry  | Serbian Chemical Society   | International Society for Nucleosides, Nucleotides and Nucleic Acids  | Association of the British Pharmaceutical Industry  | American Association of Pharmaceutical Scientists  | Royal Society of Medicinal Chemistry  | The European Federation for Medicinal Chemistry  | German Chemical Society 

Recommended: Pharmaceutical chemistry conference | Drug discovery chemistry conference | Medicinal chemistry meeting| Medicinal chemistry congress | Drug chemistry Symposia| Congress on Drug Discovery | Pharmaceutical Drugs meet | Drug Discovery meeting

Session on Allosteric Modulators

Allosteric modulators in pharmacology are a group of substances that bind to a receptor to alter the stimulus response of that receptor. Whether positive, negative or neutral modulators are involved. Both modulators and agonists can be called receptor ligands Positive forms improve the receptor response by either increasing the likelihood of an agonist binding to a receptor or improving the receptor's ability to activate or both. Negative forms the attraction and/or effectiveness of the agonist. Neutral forms do not affect agonistic activity, but can avoid binding to an allosteric site by other modulators. Even acting as allosteric agonists are some modulators.

Related societies / Associations: American Association of Pharmaceutical Scientists  | Association of the British Pharmaceutical Industry  | Serbian Chemical Society  | International Society for Nucleosides, Nucleotides and Nucleic Acids | ACS Division of Medicinal Chemistry | European Chemical Society | German Chemical Society | Royal Society of Medicinal Chemistry  | The European Federation for Medicinal Chemistry

Recommended: Drug chemistry Symposia| Pharmaceutical chemistry conference | Congress on Drug Discovery | Drug Discovery meeting | Drug discovery chemistry conference | Medicinal chemistry meeting | Pharmaceutical Drugs meet | Medicinal chemistry congress

Session on Epigenetic Pharmacology Chemistry

Epigenetics is the study of modifications to DNA that change the way genes are expressed. It does not alter the underlying genetic code of an individual. Epigenetic modifications affect when genes are turned on and off. New techniques in the understanding of gene regulation have shown there to be much more regulation of the genome than first thought, through epigenetic chemistry mechanisms. These epigenetic mechanisms are processes that have evolved either to completely shut down gene expression or to fine-tune any genetic activation that occurs. Such types of pharmaceutical chemistry systems are present in all genes and include chromatin modifications and remodelling, DNA methylation (such as CpG island methylation rates) and histone covalent modifications (e.g. acetylation, methylation), RNA interference by short interfering RNAs (siRNAs) and long non-coding RNAs (ncRNAs).Newer classes of drugs regulate epigenetic mechanisms to counteract disease states in humans.

Related societies / Associations: German Chemical Society | ACS Division of Medicinal Chemistry | European Chemical Society | Royal Society of Medicinal Chemistry | The European Federation for Medicinal Chemistry | International Society for Nucleosides, Nucleotides and Nucleic Acids | Serbian Chemical Society  | American Association of Pharmaceutical Scientists  | Association of the British Pharmaceutical Industry  

Recommended: Drug Discovery meeting | Drug discovery chemistry conference| Medicinal chemistry congress | Pharmaceutical chemistry conference | Pharmaceutical Drugs meet | Medicinal chemistry meeting | Drug chemistry Symposia | Congress on Drug Discovery                    

Session on ADME Drug Chemistry     

ADME is an abbreviation for "absorption, delivery, metabolism and excretion" in pharmacokinetics and pharmacology, and describes the arrangement of a pharmaceutical compound within an organism. The four parameters all influence the drug levels and kinetics of drug delivery to the tissues and thus affect the compound's efficiency and pharmacological activity as a drug.

Related societies / Associations: The European Federation for Medicinal Chemistry | American Association of Pharmaceutical Scientists | Association of the British Pharmaceutical Industry | Serbian Chemical Society | International Society for Nucleosides, Nucleotides and Nucleic Acids | German Chemical Society | ACS Division of Medicinal Chemistry | European Chemical Society | Royal Society of Medicinal Chemistry

Recommended: Medicinal chemistry meeting | Pharmaceutical Drugs meet | Drug discovery chemistry conference | Medicinal chemistry congress | Pharmaceutical chemistry conference | Drug chemistry Symposia | Congress on Drug Discovery | Drug Discovery meeting 

Session on Cyclic peptides and constrained peptides

In the medicinal chemistry industry, synthetic macro cyclic compounds are technically compatible with the bill for new chemical entities with good drug potential, yet they can reach newer drug targets such as protein-protein interactions (PPIs) that are intracellular and more complex than conventional enzyme targets. In fact, examples of naturally occurring macrocyclics, such as cyclosporine, have become successful drug compounds. Nevertheless, synthetic macrocyclic’s ideality continues to be optimized.

Related societies / Associations: ACS Division of Medicinal Chemistry | German Chemical Society | Serbian Chemical Society | International Society for Nucleosides, Nucleotides and Nucleic Acids| American Association of Pharmaceutical Scientists | European Chemical Society  | Royal Society of Medicinal Chemistry  | The European Federation for Medicinal Chemistry | Association of the British Pharmaceutical Industry

Recommended: Pharmaceutical Drugs meet | Drug discovery chemistry conference| Medicinal chemistry congress| Pharmaceutical chemistry conference | Congress on Drug Discovery| Drug chemistry Symposia| Drug Discovery meeting | Medicinal chemistry meeting

Session on Fragment Based Drug Discovery

Fragment-based drug discovery (FBDD), is a technique used in pharmaceutical chemistry as part of the drug discovery process to identify lead compounds. Fragments are small organic molecules that are small in size and low in molecular weight. They are focused on the detection of small chemical fragments that can only bind weakly to the biological target and then expand or combine them to create a lead with a higher affinity. High-throughput screening (HTS) can be compared to FBDD. In HTS, libraries of up to millions of compounds are screened with molecular weights of about 500 Da, and nanomolar binding affinities are pursued.

Related societies / Associations: Association of the British Pharmaceutical Industry | Royal Society of Medicinal Chemistry | European Chemical Society | Serbian Chemical Society | International Society for Nucleosides, Nucleotides and Nucleic Acids | ACS Division of Medicinal Chemistry | German Chemical Society   | American Association of Pharmaceutical Scientists | The European Federation for Medicinal Chemistry

Recommended: Drug discovery chemistry conference | Medicinal chemistry congress | Pharmaceutical chemistry conference | Drug chemistry Symposia | Drug Discovery meeting | Medicinal chemistry meeting | Pharmaceutical Drugs meet | Congress on Drug Discovery

Session on Encoded Libraries for Small Molecule Discovery

DNA-encoded libraries (DELs) use chemical synthesis to create large numbers of compounds which can be screened easily and quickly on the basis of binding affinity DEL is a technique used to synthesize and screen sets of small molecule compounds on an unprecedented scale. DEL technology involves the conjugation of chemical compounds or building blocks to short fragments of DNA that serve as bar codes for identification and in some cases also guide and control chemical synthesis. The technique allows libraries to be generated massively and interrogated by selecting affinity, usually on an immobilized protein target.

Recommended: Drug chemistry Symposia | Drug discovery chemistry conference | Medicinal chemistry congress | Congress on Drug Discovery | Pharmaceutical chemistry conference | Medicinal chemistry meeting | Drug Discovery meeting | Pharmaceutical Drugs meet

Related societies / Associations: American Association of Pharmaceutical Scientists | German Chemical Society | Serbian Chemical Society | Royal Society of Medicinal Chemistry | European Chemical Society | Association of the British Pharmaceutical Industry  | International Society for Nucleosides, Nucleotides and Nucleic Acids | The European Federation for Medicinal Chemistry | ACS Division of Medicinal Chemistry

Session on Intracellular Protein-Protein Interactions

Intracellular protein-protein interactions (PPIs) arise from biochemical events mediated by electrostatic forces, including the hydrophobic effect, are high-specific physical contacts between two or more protein molecules. These complexes of protein-protein interaction (PPI) may be regarded as a type of drug target. PPI targets vary from conventional drug targets consisting of a single protein, specifically an enzyme, whose activity is aimed at a chemical inhibitor reduction. Nevertheless, the flat and wide interacting surfaces of PPIs make them less appropriate for the enzyme design strategy of the traditional groove and ball inhibitor.

Related societies / Associations: European Chemical Society | Association of the British Pharmaceutical Industry  | International Society for Nucleosides, Nucleotides and Nucleic Acids | The European Federation for Medicinal Chemistry | ACS Division of Medicinal Chemistry | German Chemical Society  | Serbian Chemical Society  | Royal Society of Medicinal Chemistry | American Association of Pharmaceutical Scientists

Recommended: Medicinal chemistry congress | Drug chemistry SymposiaDrug discovery chemistry conferencePharmaceutical chemistry conference | Pharmaceutical Drugs meetDrug Discovery meeting | Congress on Drug DiscoveryMedicinal chemistry meeting

Session on Neuropharmacology                         

Neuropharmacology is the study of how drugs affect the nervous system's cellular function and the neural processes by which they influence behaviour. There are two primary divisions behavioural and molecular. Neuropsychopharmacology (behavioural) focuses on how drugs affect human behaviour, including how drug addiction and dependence affect the brain of humans. Molecular involves the monitoring of neurochemical interactions with the overall objective is to develop drugs that have positive neurological functional effects.

Related societies / Associations: American Association of Pharmaceutical Scientists | German Chemical Society | International Society for Nucleosides, Nucleotides and Nucleic Acids | The European Federation for Medicinal Chemistry | European Chemical Society | Royal Society of Medicinal Chemistry | Association of the British Pharmaceutical Industry   | ACS Division of Medicinal Chemistry | Serbian Chemical Society

Recommended: Medicinal chemistry congress | Drug discovery chemistry conference| Pharmaceutical chemistry conference | Drug chemistry Symposia | Medicinal chemistry meeting | Drug Discovery meeting | Pharmaceutical Drugs meet | Congress on Drug Discovery

Session on Anti-Cancer Agents-Medicinal Chemistry

Anticancer drug also known as antineoplastic medicinal chemistry that is effective in treating malignant or cancerous diseases. There are several major groups of medicines for cancer, including alkylating agents, antimetabolites, natural products, and hormones. It is intended to cover all the new and ground breaking advances in medicinal chemistry and drug design for anti-cancer agent discovery.

Related societies / Associations: The European Federation for Medicinal Chemistry | ACS Division of Medicinal Chemistry | American Association of Pharmaceutical Scientists  | German Chemical Society | International Society for Nucleosides, Nucleotides and Nucleic Acids | European Chemical Society | Royal Society of Medicinal Chemistry | Association of the British Pharmaceutical Industry  | Serbian Chemical Society

Recommended: Pharmaceutical chemistry conference | Medicinal chemistry congress | Drug discovery chemistry conference | Medicinal chemistry meetingDrug chemistry SymposiaDrug Discovery meeting | Congress on Drug DiscoveryPharmaceutical Drugs meet

Session on Cytokine Receptor

Cytokines are a large group of proteins that are secreted by specific cells of immune system. These cytokine molecules help cells interact in the immune response and promote cell movement to inflammation, infection and wound sites. These are the major contributors of medicinal chemistry and their trans membrane glycoproteins commonly composed of several subunits. They function by binding different membrane receptors on their target cells.

Related societies / Associations: European Chemical Society| Royal Society of Medicinal Chemistry | The European Federation for Medicinal Chemistry | ACS Division of Medicinal Chemistry | American Association of Pharmaceutical Scientists | German Chemical Society | International Society for Nucleosides, Nucleotides and Nucleic Acids | Serbian Chemical Society  | Association of the British Pharmaceutical Industry

Recommended: Medicinal chemistry congress | Pharmaceutical chemistry conference | Drug discovery chemistry conference | Drug chemistry Symposia | Drug Discovery meeting  | Medicinal chemistry meeting | Congress on Drug Discovery | Pharmaceutical Drugs meet

Session on Targeted Covalent Inhibitors

Targeted covalent inhibitors (TCIs) are inhibitors that are rationally engineered with the concept of pharmaceutical chemistry to bind to their target protein. These inhibitors have a bond-forming functional group with low chemical reactivity that is positioned to react quickly at the target site with a particular nucleophile residue and form a bond after binding to the target protein.

Related societies / Associations: International Society for Nucleosides, Nucleotides and Nucleic Acids | Serbian Chemical Society | European Chemical Society | Royal Society of Medicinal Chemistry | ACS Division of Medicinal Chemistry | German Chemical Society | American Association of Pharmaceutical Scientists | The European Federation for Medicinal Chemistry | Association of the British Pharmaceutical Industry

Recommended: Medicinal chemistry congress| Pharmaceutical chemistry conference | Drug discovery chemistry conference | Drug chemistry Symposia | Drug Discovery meeting | Medicinal chemistry meeting | Congress on Drug Discovery | Pharmaceutical Drugs meet

Market analysis

OVERVIEW ON DRUG DISCOVERY MARKET

The driving factors for drug discovery market growth include the increasing prevalence of a wide range of diseases (such as cardiovascular and CNS related disorders), rising healthcare spending, and upcoming patent expiration of blockbuster drugs.

Globally, the diverse range of diseases, primarily cardiovascular diseases, system disorder of central nerves, infectious diseases, diabetes, and complications related to the kidneys, has a high prevalence. Thus, the growing prevalence and global burden of a diverse range of diseases among all age groups drives the demand for drug discovery and its market

There has been a rising demand for specialty medicines in recent years that are expected to potentially have a positive impact on the market for small molecule drug discovery.

Pharmaceutical chemistry has a wide range of fields related with identification, synthesis and production of drug for therapeutic applications. The recent market trends observed with medicinal chemistry operations are outsourced by most of the pharmaceutical companies because this helps the companies to pace up the research process making it time and cost efficient.
The outsourcing pattern was observed from the North American and European pharmaceutical companies. Drug research is expected to be mainly practiced in small specialized biopharmaceutical companies around the world in the United Kingdom, the United States, Western Europe, Eastern Europe, China, India, Brazil, South Africa and Mexico as investment time and risks in this operating model are comparatively less than conventional.



Study Period: 2016-2024

Base Year: 2018

Fastest Growing Market: Asia Pacific, Europe

Largest Market: North America

WHY VIENNA?
Vienna is an important location in the heart of Europe, where a large number of international organizations and non-governmental organizations can be representedVienna is the capital of Austria and largest city. Austria has one of the world's best healthcare systems, with international access to medical services exemplary. 

TOP 10 UNIVERSITIES IN THE WORLD

              ·        Massachusetts Institute of Technology (MIT)

              ·         University of California – Berkeley
      ·         University of Cambridge
      ·         Harvard University
      ·         Stanford University
      ·         University of Oxford
      ·         California Institute of Technology
      ·         University of California – Los Angeles
      ·         ETH Zürich

TOP 10 UNIVERSITIES IN AUSTRIA

      ·         University of Vienna

      ·         Vienna University of Technology

      ·         Graz University of Technology

      ·         University of Innsbruck

      ·         University of Graz

      ·         Johannes Kepler University of Linz

      ·         University of Bodenkultur Wien

TARGETED AUDIENCE

     ·            Medical chemist

     ·            Toxicologists

     ·             Pharmacologists

     ·             Clinical trial technicians

     ·             Pharmacists

     ·             Laboratory owners

     ·             Research enthusiasts

     ·             Microbiologists

     ·             Immunologists

     ·             Pharmacology and medical chemistry students

     ·             Professors

     ·             Pharmacology professionals

     ·             Pharmacy schools

     ·             Doctors

     ·             Genetic Professionals

     ·             Forensic Professionals

     ·             Pharmaceutical companies

     ·             Research Institutes and members

     ·             Chemistry students

     ·             Chemical engineering students and professors

     ·             Supply Chain companies

     ·              Manufacturing Companies

     ·             Training Institutes

     ·              Business Entrepreneurs

     ·               Journal Editorial members

     ·              University heads

     ·              Delegates


Organizing Committee
OCM Member
alain.fymat fiimas.org alain.fymat@fiimas.org
International Institute of Medicine and Science
California, USA
OCM Member
Aizman Roman <aizman.roman@yandex.ru>
Doctor of Biological Sciences, Head of the Dept. of Anatomy, Physiology, and Life Safety
Novosibirsk State Pedagogical University
Saint Petersburg, Russia

To Collaborate Scientific Professionals around the World

Conference Date June 1-2, 2020
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Join The Discussion

Allied Academies Global Conference Directory

Mail us at

General Queries
drugdiscovery@alliedforums.org
Registration Queries
drugdiscovery@alliedconference.org
Exhibitor Queries
drugdiscovery@alliedseries.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

Insurance

Registration fees do not include insurance of any kind.

Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.

Press/Media

Press permission must be obtained from Allied Academies Conferences Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact drugdiscovery@alliedconferences.org to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrants account.

This cancellation policy was last updated on December 12, 2016.

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to drugdiscovery@alliedconferences.org

Cancellation Policy

If Allied Academies cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of cancellation.

Postponement

If Allied Academies postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to drugdiscovery@alliedconferences.org . Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

 

Copyright © 2020-2021 Allied Academies, All Rights Reserved.